<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Phys Ther Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Phys Ther Sci</journal-id><journal-id journal-id-type="publisher-id">JPTS</journal-id><journal-title-group><journal-title>Journal of Physical Therapy Science</journal-title></journal-title-group><issn pub-type="ppub">0915-5287</issn><issn pub-type="epub">2187-5626</issn><publisher><publisher-name>The Society of Physical Therapy Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27190482</article-id><article-id pub-id-type="pmc">4868242</article-id><article-id pub-id-type="publisher-id">jpts-2015-1105</article-id><article-id pub-id-type="doi">10.1589/jpts.28.1355</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effects of aerobic exercise training on peripheral brain-derived neurotrophic
factor and eotaxin-1 levels in obese young men</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cho</surname><given-names>Su Youn</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Roh</surname><given-names>Hee Tae</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref></contrib><aff id="aff1"><label>1)</label> Exercise Physiology Laboratory, Department of Physical
Education, Yonsei University, Republic of Korea</aff><aff id="aff2"><label>2)</label> Department of Physical Education, College of Arts and
Physical Education, Dong-A University, Republic of Korea</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Hee Tae Roh, Department of Physical Education, College of Arts and
Physical Education, Dong-A University: 37 Nakdong-daero 550 beon-gil, Hadan-dong, Saha-gu,
Busan 604-714, Republic of Korea. (E-mail: <email xlink:href="dau0409@dau.ac.kr">dau0409@dau.ac.kr</email>)</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>4</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2016</year></pub-date><volume>28</volume><issue>4</issue><fpage>1355</fpage><lpage>1358</lpage><history><date date-type="received"><day>21</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>16</day><month>1</month><year>2016</year></date></history><permissions><copyright-statement>2016&#x000a9;by the Society of Physical Therapy Science. Published by IPEC
Inc.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><p>[Purpose] The aim of the present study was to investigate the effects of aerobic exercise
training on the levels of peripheral brain-derived neurotrophic factor and eotaxin-1 in
obese young men. [Subjects and Methods] The subjects included sixteen obese young men with
a body mass index greater than 25&#x02005;kg/m<sup>2</sup>. They were randomly divided between
control and exercise groups (n = 8 in each group). The exercise group performed treadmill
exercise for 40&#x02005;min, 3 times a week for 8 weeks at the intensity of 70% heart rate
reserve. Blood collection was performed to examine the levels of serum glucose, plasma
malonaldehyde, serum brain-derived neurotrophic factor, and plasma eotaxin-1 before and
after the intervention (aerobic exercise training). [Results] Following the intervention,
serum BDNF levels were significantly higher, while serum glucose, plasma MDA, and plasma
eotaxin-1 levels were significantly lower than those prior to the intervention in the
exercise group. [Conclusion] Aerobic exercise training can induce neurogenesis in obese
individuals by increasing the levels of brain-derived neurotrophic factor and reducing the
levels of eotaxin-1. Alleviation of oxidative stress is possibly responsible for such
changes.</p></abstract><kwd-group><title>Key words</title><kwd>Aerobic exercise</kwd><kwd>BDNF</kwd><kwd>CCL11</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Chemokines are a family of small cytokines that regulate leukocyte migration by inducing
chemotaxis of specific cells. Chemokines are produced in almost all eukaryotic cells that
constitute blood and other tissues. For example, chemokines of the CC subfamily are secreted
by epithelial cells and fibroblasts during inflammatory reactions<xref rid="r1" ref-type="bibr">1</xref><sup>)</sup>. Eotaxin-1 (CCL11), a member of the CC chemokine family
secreted by epithelial cells, fibroblasts, macrophages, and eosinophils, has been reported
to play an important role in eosinophil infiltration during allergic inflammation<xref rid="r1" ref-type="bibr">1</xref><sup>)</sup>. Accordingly, majority of previous studies
on the function and role of CCL11 focused mainly on inflammatory airway diseases, such as
asthma<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r2" ref-type="bibr">2</xref><sup>)</sup>. However, recently, studies have provided evidence regarding the
neurobiological relevance of CCL11<xref rid="r3" ref-type="bibr">3</xref><sup>)</sup>. For
example, in the study of Villeda et al., a decrease in long-term potentiation of synaptic
transmission, a neurophysiological index related to learning ability, has been observed in
the brains of mice injected with CCL11<xref rid="r4" ref-type="bibr">4</xref><sup>)</sup>.
In addition, that study revealed that CCL11 is a blood-borne factor inhibiting
neurogenesis<xref rid="r4" ref-type="bibr">4</xref><sup>)</sup>.</p><p>On the other hand, it has been reported that regular exercise not only reduces high
oxidative stress level caused by obesity, but also induces neurogenesis by increasing
expression of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF)<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r6" ref-type="bibr">6</xref><sup>)</sup>.
Dramatic changes in oxidative stress levels could play an important role in neurotrophic
factor expression as well as in CCL11 release<xref rid="r7" ref-type="bibr">7</xref>, <xref rid="r8" ref-type="bibr">8</xref><sup>)</sup>. In addition, Loughrey et al. revealed
increased circulating CCL11 levels in patients with a metabolic syndrome that included
obesity as a clinical manifestation<xref rid="r9" ref-type="bibr">9</xref><sup>)</sup>. Choi
et al. reported that although CCL11 levels were significantly higher in patients with
central obesity, regular exercise training could reduce their plasma CCL11 levels<xref rid="r10" ref-type="bibr">10</xref><sup>)</sup>. However, there has been very limited
research into dynamics of neurogenesis in obese human subjects and the relationship between
CCL11 levels and regular exercise has not been properly studied.</p><p>Therefore, for the present study, obese young men were recruited with the objective of
defining the effect of regular aerobic exercise intervention on the content of malonaldehyde
(MDA), an oxidative stress marker, and on the resulting changes in peripheral BDNF and CCL11
levels.</p></sec><sec sec-type="methods" id="s2"><title>SUBJECTS AND METHODS</title><p>Sixteen obese young men between 20&#x02013;26&#x02005;years of age volunteered as subjects for the present
study. All subjects had to meet the following criteria before enrollment in the study: 1)
BMI above 25&#x02005;kg/m<sup>2</sup> and waist circumference above 90&#x02005;cm, 2) no participation in
regular physical activity programs, and 3) no history of cardiovascular, metabolic, or
respiratory diseases. Subjects were randomly assigned into a control (CON) group or an
exercise (EX) group, with 8 subjects in each group. The characteristics of the subjects are
shown in <xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Characteristics of the subjects</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">CON (n = 8)</th><th align="center" rowspan="1" colspan="1">EX (n = 8)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">22.3&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">22.9&#x000b1;2.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Height (cm)</td><td align="center" rowspan="1" colspan="1">173.6&#x000b1;6.3</td><td align="center" rowspan="1" colspan="1">172.8&#x000b1;4.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="center" rowspan="1" colspan="1">83.8&#x000b1;10.3</td><td align="center" rowspan="1" colspan="1">85.6&#x000b1;8.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Fat mass (kg)</td><td align="center" rowspan="1" colspan="1">24.3&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">24.6&#x000b1;5.2</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">27.7&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">28.7&#x000b1;2.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Body fat (%)</td><td align="center" rowspan="1" colspan="1">28.8&#x000b1;2.3</td><td align="center" rowspan="1" colspan="1">28.7&#x000b1;4.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Waist circumference (cm)</td><td align="center" rowspan="1" colspan="1">99.8&#x000b1;4.8</td><td align="center" rowspan="1" colspan="1">100.0&#x000b1;5.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Resting SBP (mmHg)</td><td align="center" rowspan="1" colspan="1">126.0&#x000b1;7.3</td><td align="center" rowspan="1" colspan="1">126.9&#x000b1;9.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Resting DBP (mmHg)</td><td align="center" rowspan="1" colspan="1">81.4&#x000b1;5.3</td><td align="center" rowspan="1" colspan="1">83.8&#x000b1;5.9</td></tr><tr><td align="left" rowspan="1" colspan="1">VO<sub>2</sub>max (mL/kg/min)</td><td align="center" rowspan="1" colspan="1">43.9&#x000b1;7.2</td><td align="center" rowspan="1" colspan="1">42.4&#x000b1;5.9</td></tr></tbody></table><table-wrap-foot><p>Data are presented as mean &#x000b1; SD. BMI: body mass index; SBP: systolic blood pressure;
DBP: diastolic blood pressure</p></table-wrap-foot></table-wrap>. The study conformed to the standards set by the latest revision of the
Declaration of Helsinki. All subjects read and signed a written informed consent statement
consistent with the guidelines set by the Department of Physical Education at Yonsei
University.</p><p>Anthropometric measurements included measurements of height, body composition, resting
blood pressure (BP), and maximal oxygen uptake (VO<sub>2</sub>max). Height and body
composition were measured using a stadiometer (SECA213; SECA, Hamburg, Germany) and a
bioimpedance analysis (BIA) device (Inbody720; Biospace, Seoul, Korea), respectively. BP was
measured in a seated position using standard auscultation procedures and a mercury
sphygmomanometer (Trimline; PyMaH, Somerville, NJ, USA). Each subject was wearing a gas
analyzer (MetaMax 3B; Cortex, Leipzig, Germany) that evaluated respiratory parameters using
the breath-by-breath method and VO<sub>2</sub>max was measured on a treadmill (Q65; Quinton,
Seattle, WA, USA) according to the Bruce protocol.</p><p>All subjects in the EX group had undergone the supervised treadmill running exercise [70%
of the heart rate reserve (HRR), 40&#x02005;min each] sessions 3 times a week for 8 weeks, while
those in the CON group just maintained their usual lifestyles.</p><p>Ten milliliters of blood was collected from the antecubital vein of each subject before and
after the intervention using a 22-gauge needle, a serum separator tube (Becton Dickinson,
Franklin Lakes, NJ, USA), and an ethylenediamine tetra-acetic acid tube (Becton Dickinson,
Franklin Lakes, NJ, USA). Collected blood samples were centrifuged for 15&#x02005;min at 1,000 &#x000d7; g
and then stored at &#x02212;80&#x02005;&#x000b0;C until further analysis. Serum glucose was determined by the
hexokinase method using a commercially available glucose/hexokinase assay kit (Pointe
Scientific, Canton, MI, USA). The analyses of plasma MDA, serum BDNF, and plasma CCL11
levels were carried out using an OxiSelect<sup>TM</sup> MDA Adduct Competitive ELISA Kit
(Cell Biolabs, San Diego, CA, USA), a human BDNF ELISA Kit (R&#x00026;D Systems, Minneapolis,
MN, USA), and a human CCL11/Eotaxin Immunoassay Kit (R&#x00026;D Systems, Minneapolis, MN, USA),
respectively. A microplate reader (EMax; Molecular device, Sunnyvale, CA, USA) was used to
measure absorbance at 450&#x02005;nm.</p><p>Statistical analyses were performed with SPSS version 21.0 for Windows (SPSS Inc., Chicago,
IL, USA). Data are presented as the means &#x000b1; standard deviation (SD), unless otherwise
stated. Independent Student&#x02019;s t-tests were conducted to compare baseline levels of all
variables between the CON and EX groups. To reveal differences between normally distributed
data, the two-way repeated analysis of variance (ANOVA) was employed. When significant time
by group interactions occurred, simple main effects were assessed using independent and
paired Student&#x02019;s <italic>t</italic>-tests. Level of significance was set at 0.05.</p></sec><sec sec-type="results" id="s3"><title>RESULTS</title><p>The comparison of anthropometric and biochemical characteristics for the two groups before
and after intervention is shown in <xref rid="tbl_002" ref-type="table">Table
2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Comparison of anthropometric and biochemical characteristics before and after
intervention</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="center" valign="middle" colspan="1">Variables</th><th colspan="2" align="center" rowspan="1">CON (n = 8)</th><th colspan="2" align="center" rowspan="1">EX (n = 8)</th></tr><tr><th colspan="2" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Before</th><th align="center" rowspan="1" colspan="1">After</th><th align="center" rowspan="1" colspan="1">Before</th><th align="center" rowspan="1" colspan="1">After</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="center" rowspan="1" colspan="1">83.8&#x000b1;10.3</td><td align="center" rowspan="1" colspan="1">83.5&#x000b1;10.0</td><td align="center" rowspan="1" colspan="1">85.6&#x000b1;8.3</td><td align="center" rowspan="1" colspan="1">79.5&#x000b1;7.3<sup>*</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">27.7&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">27.6&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">28.7&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">26.6&#x000b1;1.9<sup>*</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Fat mass (kg)</td><td align="center" rowspan="1" colspan="1">24.3&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">24.0&#x000b1;4.7</td><td align="center" rowspan="1" colspan="1">24.6&#x000b1;5.2</td><td align="center" rowspan="1" colspan="1">19.1&#x000b1;4.5<sup>*</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Body fat (%)</td><td align="center" rowspan="1" colspan="1">28.8&#x000b1;2.3</td><td align="center" rowspan="1" colspan="1">28.7&#x000b1;2.0</td><td align="center" rowspan="1" colspan="1">28.7&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">25.1&#x000b1;4.4<sup>*</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Waist circumference (cm)</td><td align="center" rowspan="1" colspan="1">99.8&#x000b1;4.8</td><td align="center" rowspan="1" colspan="1">99.0&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">100.0&#x000b1;5.8</td><td align="center" rowspan="1" colspan="1">91.6&#x000b1;4.3<sup>*</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">VO<sub>2</sub>max (ml/kg/min)</td><td align="center" rowspan="1" colspan="1">43.9&#x000b1;7.2</td><td align="center" rowspan="1" colspan="1">43.4&#x000b1;5.4</td><td align="center" rowspan="1" colspan="1">42.4&#x000b1;5.9</td><td align="center" rowspan="1" colspan="1">49.1&#x000b1;4.3<sup>&#x0222b;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose (mg/dl)</td><td align="center" rowspan="1" colspan="1">94.6&#x000b1;2.6</td><td align="center" rowspan="1" colspan="1">94.5&#x000b1;3.2</td><td align="center" rowspan="1" colspan="1">94.4&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">91.7&#x000b1;4.3<sup>*</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">MDA (mmol/ml)</td><td align="center" rowspan="1" colspan="1">5.7&#x000b1;0.5</td><td align="center" rowspan="1" colspan="1">5.7&#x000b1;0.6</td><td align="center" rowspan="1" colspan="1">5.7&#x000b1;0.4</td><td align="center" rowspan="1" colspan="1">5.1&#x000b1;0.8<sup>*</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">BDNF (ng/ml)</td><td align="center" rowspan="1" colspan="1">24.8&#x000b1;4.9</td><td align="center" rowspan="1" colspan="1">25.1&#x000b1;4.9</td><td align="center" rowspan="1" colspan="1">24.8&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">29.9&#x000b1;5.3<sup>&#x0222b;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">CCL11 (pg/ml)</td><td align="center" rowspan="1" colspan="1">71.7&#x000b1;12.5</td><td align="center" rowspan="1" colspan="1">72.7&#x000b1;10.9</td><td align="center" rowspan="1" colspan="1">72.8&#x000b1;14.2</td><td align="center" rowspan="1" colspan="1">68.5&#x000b1;11.9<sup>*</sup></td></tr></tbody></table><table-wrap-foot><p>Data are presented as the mean &#x000b1; SD. BMI, body mass index. Symbols * and <sup>&#x0222b;</sup>
indicate significantly lower or significantly higher values, respectively, in the same
subjects compared to the values obtained before the start of the intervention period
(p &#x0003c; 0.05)</p></table-wrap-foot></table-wrap>. Following intervention, repeated measures ANOVA demonstrated a significant
effect of treatment for weight (F = 29.546, p &#x0003c; 0.001), BMI (F = 26.859, p &#x0003c; 0.001),
fat mass (F = 31.632, p &#x0003c; 0.001), body fat (F = 19.947, p = 0.001), waist circumference
(F = 29.126, p &#x0003c; 0.001), VO<sub>2</sub>max (F = 18.613, p = 0.001), serum glucose levels
(F = 12.754, p = 0.003), plasma MDA levels (F = 5.218, p = 0.038), serum BDNF levels (F =
12.834, p = 0.003), and plasma CCL11 levels (F = 9.178, p = 0.009). Following the
intervention, BMI, fat mass, body fat, waist circumference, serum glucose levels, plasma MDA
levels, and plasma CCL11 levels were significantly lower, while VO<sub>2</sub>max and serum
BDNF levels were significantly higher when compared to values prior to the intervention in
the EX group (p &#x0003c; 0.05).</p></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><p>Obesity not only increases the rate of occurrence of type 2 diabetes mellitus,
hypertension, and cardiovascular disease<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r12" ref-type="bibr">12</xref><sup>)</sup>, but it has also been recently reported to
be closely associated with the development of neurodegenerative disorders<xref rid="r13" ref-type="bibr">13</xref>, <xref rid="r14" ref-type="bibr">14</xref><sup>)</sup>. One of plausible causes of neurodegeneration is obesity-induced
increase in the level of high oxidative stress in the body<xref rid="r15" ref-type="bibr">15</xref><sup>)</sup>. In our study, to examine the effect of regular aerobic exercise on
oxidative stress level and neurogenesis in obese subjects, the peripheral levels of MDA,
BDNF, and CCL11 were measured. It was found that plasma MDA and CCL11 levels were decreased,
whereas serum BDNF levels were significantly increased after 8 weeks of aerobic exercise.
This result corroborates observations in previous studies that showed significantly lower
plasma MDA and CCL11 levels and, at the same time, significantly higher serum BDNF levels
after regular exercise training in patients with a metabolic syndrome that included obesity
as a clinical feature. Tunkamnerdthai et al. reported that 8 weeks of low-intensity exercise
significantly decreased plasma MDA levels in overweight patients with type 2 diabetes<xref rid="r5" ref-type="bibr">5</xref><sup>)</sup>, while Choi et al. found that 12 weeks of
exercise training significantly reduced plasma CCL11 levels in patients with obesity<xref rid="r10" ref-type="bibr">10</xref><sup>)</sup>. In addition, Lee et al. observed
significantly increased serum BDNF levels in obese patients after 12 weeks of aerobic
exercise<xref rid="r6" ref-type="bibr">6</xref><sup>)</sup>.</p><p>In the present study, changes in the indexes related to obesity and levels of serum glucose
and plasma MDA suggested that the significantly lower plasma CCL11 levels and significantly
higher serum BDNF content were due to regular aerobic exercise. By inducing the improvement
of body composition and reducing fasting glucose level, regular exercise alleviated
oxidative stress in the body. This interpretation is supported by previous studies, which
had reported that obesity elevates oxidative stress levels and induces CCL11 release
following the increase in the reactive oxygen species (ROS) production<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r15" ref-type="bibr">15</xref><sup>)</sup>. Increased
oxidative stress could, in turn, induce down-regulation of neurotrophic factors<xref rid="r7" ref-type="bibr">7</xref><sup>)</sup>. In addition, it was reported that high
blood glucose concentration induces ROS production via various biochemical signaling
cascades, such as glucose autoxidation, increase in advanced glycation end-products
synthesis, and activation of the polyol pathway, thereby leading to increased oxidative
stress in a variety of tissues<xref rid="r16" ref-type="bibr">16</xref><sup>)</sup>. On the
other hand, it has been reported that in addition to improving obesity symptoms, regular
exercise could reduce fasting glucose concentration and levels of MDA, an indirect oxidative
stress marker<xref rid="r17" ref-type="bibr">17</xref>, <xref rid="r18" ref-type="bibr">18</xref><sup>)</sup>.</p><p>In conclusion, it is suggested that regular exercise can induce neurogenesis in obese
individuals by increasing BDNF levels, while concomitantly reducing CCL11 levels.
Alleviation of oxidative stress could be a principal mediator of these physiological and
biochemical changes.</p></sec></body><back><ack><p>This work was supported by the National Research Foundation of Korea Grant funded by the
Korean Government (NRF-2013S1A5B5A07049580).</p></ack><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Luster</surname><given-names>AD</given-names></name></person-group>: <article-title>Chemokines&#x02014;chemotactic cytokines that mediate
inflammation</article-title>. <source>N Engl J Med</source>, <year>1998</year>,
<volume>338</volume>: <fpage>436</fpage>&#x02013;<lpage>445</lpage>. <pub-id pub-id-type="pmid">9459648</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Bi</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>: <article-title>CCL11 as a potential diagnostic marker for
asthma?</article-title><source>J Asthma</source>, <year>2014</year>,
<volume>51</volume>: <fpage>847</fpage>&#x02013;<lpage>854</lpage>. <pub-id pub-id-type="pmid">24796647</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Stuart</surname><given-names>MJ</given-names></name><name><surname>Singhal</surname><given-names>G</given-names></name><name><surname>Baune</surname><given-names>BT</given-names></name></person-group>: <article-title>Systematic review of the neurobiological relevance of
chemokines to psychiatric disorders</article-title>. <source>Front Cell
Neurosci</source>, <year>2015</year>, <volume>9</volume>: <fpage>357</fpage>.
<pub-id pub-id-type="pmid">26441528</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Villeda</surname><given-names>SA</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Mosher</surname><given-names>KI</given-names></name><etal>et al.</etal></person-group>: <article-title>The ageing systemic milieu negatively regulates
neurogenesis and cognitive function</article-title>. <source>Nature</source>,
<year>2011</year>, <volume>477</volume>: <fpage>90</fpage>&#x02013;<lpage>94</lpage>.
<pub-id pub-id-type="pmid">21886162</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Tunkamnerdthai</surname><given-names>O</given-names></name><name><surname>Auvichayapat</surname><given-names>P</given-names></name><name><surname>Donsom</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>: <article-title>Improvement of pulmonary function with arm swing exercise
in patients with type 2 diabetes</article-title>. <source>J Phys Ther Sci</source>,
<year>2015</year>, <volume>27</volume>: <fpage>649</fpage>&#x02013;<lpage>654</lpage>.
<pub-id pub-id-type="pmid">25931700</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Lee</surname><given-names>SS</given-names></name><name><surname>Yoo</surname><given-names>JH</given-names></name><name><surname>Kang</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>: <article-title>The effects of 12 weeks regular aerobic exercise on
brain-derived neurotrophic factor and inflammatory factors in juvenile obesity and type
2 diabetes mellitus</article-title>. <source>J Phys Ther Sci</source>,
<year>2014</year>, <volume>26</volume>: <fpage>1199</fpage>&#x02013;<lpage>1204</lpage>.
<pub-id pub-id-type="pmid">25202180</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Gardiner</surname><given-names>J</given-names></name><name><surname>Barton</surname><given-names>D</given-names></name><name><surname>Overall</surname><given-names>R</given-names></name><etal>et al.</etal></person-group>: <article-title>Neurotrophic support and oxidative stress: converging
effects in the normal and diseased nervous system</article-title>.
<source>Neuroscientist</source>, <year>2009</year>, <volume>15</volume>:
<fpage>47</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="pmid">19218230</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Parajuli</surname><given-names>B</given-names></name><name><surname>Horiuchi</surname><given-names>H</given-names></name><name><surname>Mizuno</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>: <article-title>CCL11 enhances excitotoxic neuronal death by producing
reactive oxygen species in microglia</article-title>. <source>Glia</source>,
<year>2015</year>, <volume>63</volume>: <fpage>2274</fpage>&#x02013;<lpage>2284</lpage>.
<pub-id pub-id-type="pmid">26184677</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Loughrey</surname><given-names>BV</given-names></name><name><surname>McGinty</surname><given-names>A</given-names></name><name><surname>Young</surname><given-names>IS</given-names></name><etal>et al.</etal></person-group>: <article-title>Increased circulating CC chemokine levels in the metabolic
syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized
controlled trial</article-title>. <source>Clin Endocrinol (Oxf)</source>,
<year>2013</year>, <volume>79</volume>: <fpage>800</fpage>&#x02013;<lpage>806</lpage>.
<pub-id pub-id-type="pmid">23170936</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>Choi</surname><given-names>KM</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Cho</surname><given-names>GJ</given-names></name><etal>et al.</etal></person-group>: <article-title>Effect of exercise training on plasma visfatin and eotaxin
levels</article-title>. <source>Eur J Endocrinol</source>, <year>2007</year>,
<volume>157</volume>: <fpage>437</fpage>&#x02013;<lpage>442</lpage>. <pub-id pub-id-type="pmid">17893257</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>YE</given-names></name></person-group>: <article-title>Effects of exercise on glycemic control in type 2 diabetes
mellitus in Koreans: the fifth Korea National Health and Nutrition Examination Survey
(KNHANES V)</article-title>. <source>J Phys Ther Sci</source>, <year>2015</year>,
<volume>27</volume>: <fpage>3559</fpage>&#x02013;<lpage>3564</lpage>. <pub-id pub-id-type="pmid">26696738</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>DY</given-names></name><name><surname>Seo</surname><given-names>BD</given-names></name><name><surname>Kim</surname><given-names>DJ</given-names></name></person-group>: <article-title>Effect of walking exercise on changes in cardiorespiratory
fitness, metabolic syndrome markers, and high-molecular-weight adiponectin in obese
middle-aged women</article-title>. <source>J Phys Ther Sci</source>, <year>2014</year>,
<volume>26</volume>: <fpage>1723</fpage>&#x02013;<lpage>1727</lpage>. <pub-id pub-id-type="pmid">25435686</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Heneka</surname><given-names>MT</given-names></name><name><surname>Carson</surname><given-names>MJ</given-names></name><name><surname>El Khoury</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>: <article-title>Neuroinflammation in Alzheimer&#x02019;s disease</article-title>.
<source>Lancet Neurol</source>, <year>2015</year>, <volume>14</volume>:
<fpage>388</fpage>&#x02013;<lpage>405</lpage>. <pub-id pub-id-type="pmid">25792098</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>van Dijk</surname><given-names>G</given-names></name><name><surname>van Heijningen</surname><given-names>S</given-names></name><name><surname>Reijne</surname><given-names>AC</given-names></name><etal>et al.</etal></person-group>: <article-title>Integrative neurobiology of metabolic diseases,
neuroinflammation, and neurodegeneration</article-title>. <source>Front
Neurosci</source>, <year>2015</year>, <volume>9</volume>: <fpage>173</fpage>.
<pub-id pub-id-type="pmid">26041981</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Pitocco</surname><given-names>D</given-names></name><name><surname>Tesauro</surname><given-names>M</given-names></name><name><surname>Alessandro</surname><given-names>R</given-names></name><etal>et al.</etal></person-group>: <article-title>Oxidative stress in diabetes: implications for vascular
and other complications</article-title>. <source>Int J Mol Sci</source>,
<year>2013</year>, <volume>14</volume>: <fpage>21525</fpage>&#x02013;<lpage>21550</lpage>.
<pub-id pub-id-type="pmid">24177571</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Tangvarasittichai</surname><given-names>S</given-names></name></person-group>: <article-title>Oxidative stress, insulin resistance, dyslipidemia and
type 2 diabetes mellitus</article-title>. <source>World J Diabetes</source>,
<year>2015</year>, <volume>6</volume>: <fpage>456</fpage>&#x02013;<lpage>480</lpage>.
<pub-id pub-id-type="pmid">25897356</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Ozcelik</surname><given-names>O</given-names></name><name><surname>Ozkan</surname><given-names>Y</given-names></name><name><surname>Karatas</surname><given-names>F</given-names></name><etal>et al.</etal></person-group>: <article-title>Exercise training as an adjunct to orlistat therapy
reduces oxidative stress in obese subjects</article-title>. <source>Tohoku J Exp
Med</source>, <year>2005</year>, <volume>206</volume>:
<fpage>313</fpage>&#x02013;<lpage>318</lpage>. <pub-id pub-id-type="pmid">15997202</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Buresh</surname><given-names>R</given-names></name></person-group>: <article-title>Exercise and glucose control</article-title>. <source>J
Sports Med Phys Fitness</source>, <year>2014</year>, <volume>54</volume>:
<fpage>373</fpage>&#x02013;<lpage>382</lpage>. <pub-id pub-id-type="pmid">25034542</pub-id></mixed-citation></ref></ref-list></back></article>